NJgolfer

WuXi Pharmatech Reports Another Healthy Quarter

Also held WX since last November.
I think the trends to CROs, China labor, China economic growth, and increased US penetration makes WX an attractive long-term holding. However the secondary ADS does concern me even if it is postponed this time. I would rather see them use the Operating CF of $65MM (ttm) to grow.